KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Equity Average (2017 - 2026)

ClearPoint Neuro's Equity Average history spans 13 years, with the latest figure at $21.9 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 19.3% to $21.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.9 million, a 19.3% decrease, with the full-year FY2025 number at $26.7 million, up 14.71% from a year prior.
  • Equity Average hit $21.9 million in Q4 2025 for ClearPoint Neuro, up from $17.8 million in the prior quarter.
  • Over the last five years, Equity Average for CLPT hit a ceiling of $47.3 million in Q1 2022 and a floor of $17.8 million in Q3 2025.
  • Historically, Equity Average has averaged $32.4 million across 5 years, with a median of $30.3 million in 2023.
  • Biggest five-year swings in Equity Average: skyrocketed 6088.58% in 2021 and later tumbled 41.74% in 2025.
  • Tracing CLPT's Equity Average over 5 years: stood at $46.5 million in 2021, then fell by 17.37% to $38.4 million in 2022, then plummeted by 41.03% to $22.6 million in 2023, then increased by 20.15% to $27.2 million in 2024, then decreased by 19.3% to $21.9 million in 2025.
  • Business Quant data shows Equity Average for CLPT at $21.9 million in Q4 2025, $17.8 million in Q3 2025, and $19.9 million in Q2 2025.